Home/Filings/4/0001013762-25-004322
4//SEC Filing

Vivo Opportunity, LLC 4

Accession 0001013762-25-004322

CIK 0001484565other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 7:03 PM ET

Size

12.2 KB

Accession

0001013762-25-004322

Insider Transaction Report

Form 4
Period: 2025-03-26
Transactions
  • Sale

    Common Stock

    2025-03-27$67.80/sh1,100,000$74,580,0004,791,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
  • Sale

    Common Stock

    2025-03-28$70.60/sh333,557$23,549,1244,458,294 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
  • Sale

    Common Stock

    2025-03-26$65.80/sh400,000$26,320,0005,891,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Transactions
  • Sale

    Common Stock

    2025-03-27$67.80/sh1,100,000$74,580,0004,791,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
  • Sale

    Common Stock

    2025-03-26$65.80/sh400,000$26,320,0005,891,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
  • Sale

    Common Stock

    2025-03-28$70.60/sh333,557$23,549,1244,458,294 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Footnotes (4)
  • [F1]Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  • [F2]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $64.3 to $70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $65 to $72.8, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F4]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $67.0 to $73.8, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.

Documents

1 file

Issuer

SOLENO THERAPEUTICS INC

CIK 0001484565

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001728970

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 7:03 PM ET
Size
12.2 KB